| Name | Title | Contact Details |
|---|---|---|
Jamie Sewell |
Director of Growth | Profile |
We are a biopharmaceutical company developing first-in-class therapies for cancer. Imetelstat, a novel, first-in-class telomerase inhibitor, is our product candidate in clinical development. Telomerase enables cancer cells to maintain telomere length, which provides them with the capacity for limitless cellular replication. Imetelstat is a potent and specific inhibitor of telomerase. Based on clinical data we obtained in late 2012, we may develop imetelstat to treat one or more hematologic myeloid malignancies such as myelofibrosis, or MF, myelodysplastic syndromes, or acute myelogenous leukemia.
Medterra takes pride in providing our customers with the highest quality pure CBD, grown and processed in the USA.
ENABLE Healthcare Communications is a Herndon, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Accuquest Hearing Centers is a Hoffman Estates, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Carolina Liquid Chemistries is a Winston Salem, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.